Occupational and Environmental Medicine, Vol 56, 721-724

Future impact of genetic screening in occupational and environmental medicine

RG Rawbone

New genetic technologies open up the possibility of predictive screening, both for individual genetic risk factors for susceptibility to workplace hazards and for late onset (both single gene and multifactorial) hereditary disease. Although the initiative for testing may lie with employers and employees there are many potential stakeholders--from family members and workplace colleagues to insurers and society in general. The role of the occupational health professional will not only involve the contextual interpretation of genetic test results but also the myriad of associated ethical and moral questions. This paper considers a range of ethical issues with which the occupational health professional may be confronted as genetic technology advances.

Copyright © 1999 Occupational and Environmental Medicine
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Fishwick, D, Barber, C M, Bradshaw, L M, Harris-Roberts, J, Francis, M, Naylor, S, Ayres, J, Burge, P S, Corne, J M, Cullinan, P, Frank, T L, Hendrick, D, Hoyle, J, Jaakkola, M, Newman-Taylor, A, Nicholson, P, Niven, R, Pickering, A, Rawbone, R, Stenton, C, Warburton, C J, Curran, A D, British Thoracic Society Standards of Care Subcomm, (2008). Standards of care for occupational asthma. Thorax 63: 240-250 [Full Text]  
• Palmer, K T, Poole, J, Rawbone, R G, Coggon, D (2004). Quantifying the advantages and disadvantages of pre-placement genetic screening. Occup. Environ. Med. 61: 448-453 [Abstract] [Full Text]  
• Vahakangas, K. (2004). Ethical aspects of molecular epidemiology of cancer. Carcinogenesis 25: 465-471 [Abstract] [Full Text]